Helmholtz Gemeinschaft

Search
Browse
Statistics
Feeds

Delivery of 5-azacytidine to human cancer cells by elaidic acid esterification increases therapeutic drug efficacy

Item Type:Article
Title:Delivery of 5-azacytidine to human cancer cells by elaidic acid esterification increases therapeutic drug efficacy
Creators Name:Brueckner, B. and Rius, M. and Rivera Markelova, M. and Fichtner, I. and Hals, P.A. and Sandvold, M.L. and Lyko, F.
Abstract:Azacytidine is an established nucleoside drug that is well known for its ability to modulate epigenetic gene regulation by inhibition of DNA methylation. Despite recent advances in the clinical development of azacytidine, the use of the drug is limited by its low bioavailability and dependency on variably expressed nucleoside transporters for cellular uptake. We show here that CP-4200, an elaidic acid derivative of azacytidine, has strong epigenetic modulatory potency in human cancer cell lines, as evidenced by efficient depletion of DNA methyltransferase protein, genome-wide DNA demethylation, and robust reactivation of epigenetically silenced tumor suppressor genes. Importantly, however, the cellular uptake of CP-4200 was substantially less dependent on the nucleoside transporters that are known to be involved in azacytidine uptake. In agreement with this notion, CP-4200 showed a significantly higher antitumoral activity than azacytidine in an orthotopic mouse tumor model for acute lymphocytic leukemia. Together, these data represent a detailed characterization of the CP-4200 mode of action and suggest that elaidic acid modification improves the therapeutic efficacy of azacytidine.
Keywords:Antineoplastic Antimetabolites, Azacitidine, Tumor Cell Line, Drug Delivery Systems, Genetic Epigenesis, Esterification, Esters, Neoplastic Gene Expression Regulation, HCT116 Cells, HL-60 Cells, Biological Models, Neoplasms, Oleic Acid, Treatment Outcome, Xenograft Model Antitumor Assays, Animals, Mice
Source:Molecular Cancer Therapeutics
ISSN:1535-7163
Publisher:American Association for Cancer Research (U.S.A.)
Volume:9
Number:5
Page Range:1256-1264
Date:May 2010
Official Publication:https://doi.org/10.1158/1535-7163.MCT-09-1202
PubMed:View item in PubMed

Repository Staff Only: item control page

Open Access
MDC Library